AZ505 Catalog No.:M9501-10 which has been shown to

which has been shown to occur in human myoblasts and other cells[2]

Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders

AMD 3465 may be useful for the clinical treatment of HIV-1-infected patients

InChiKey: VSHFRHVKMYGBJL-CKUXDGONSA-N

AZ505 Catalog No.:M9501-10 which has been shown toAZ505 is a potent and highly selective inhibitor of SMYD2 with potential anticancer activity. AZ505 is composed of three distinct moieties: benzooxazinone, cyclohexyl, and dichlorophenethyl substituents. The structure of the ternary complex reveals that a single AZ505 molecule is bound in the peptide binding groove of SMYD2. Product information CAS Number: 1035227 43 0 Molecular Weight: 577. 54 Formula: C29H38Cl2N4O4 Chemical Name: N cyclohexyl 3 {[2